SCHEMBL13897952

SCHEMBL13897952

CN(C)C(=O)Nc1cccc(Nc2ncc(Br)c(NCCCN)n2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STK17A Q9UEE5 6/20 0.56
▸ STK17B O94768 2/20 0.56
▸ ULK1 O75385 1/20 0.55
▸ PDK1 Q15118 1/20 0.55
▸ ULK2 Q8IYT8 1/20 0.55
▸ PDPK1 O15530 5/20 0.54
▸ CDK2 P24941 1/20 0.54
▸ TBK1 Q9UHD2 13/20 0.52
▸ MARK3 P27448 2/20 0.52
▸ MARK4 Q96L34 2/20 0.52
▸ AURKA O14965 1/20 0.49
▸ NUAK1 O60285 1/20 0.47
▸ STK16 O75716 1/20 0.47
▸ NTRK1 P04629 1/20 0.47
▸ CSNK2A2 P19784 1/20 0.47
▸ TYK2 P29597 1/20 0.47
▸ BMPR2 Q13873 1/20 0.47
▸ AAK1 Q2M2I8 1/20 0.47
▸ NUAK2 Q9H093 1/20 0.47
▸ MKNK2 Q9HBH9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13898099 0.86 STK17A (0.55) STK17ASTK17BULK1PDK1ULK2
SCHEMBL13898239 0.83 STK17A (0.54) STK17ASTK17BULK1PDK1ULK2
SCHEMBL3865350 0.82 ULK1 (0.80) STK17ASTK17BULK1PDK1ULK2
SCHEMBL13897576 0.82 TBK1 (0.53) STK17APDPK1CDK2TBK1MARK3
SCHEMBL13897358 0.81 ULK1 (0.58) STK17ASTK17BULK1PDK1ULK2
SCHEMBL13898230 0.80 TBK1 (0.53) STK17ASTK17BULK1PDK1ULK2
SCHEMBL13897359 0.80 TBK1 (0.53) STK17ASTK17BULK1PDK1ULK2
SCHEMBL3869524 0.80 ULK1 (0.76) STK17ASTK17BULK1PDK1ULK2
SCHEMBL3383665 0.79 TBK1 (0.65) STK17ASTK17BPDPK1TBK1
SCHEMBL14112813 0.78 TBK1 (0.56) STK17ASTK17BPDPK1CDK2TBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 — — US disclosed
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 — — US disclosed
Send feedback